These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25181021)

  • 21. Is memory impairment a rate limiter in cognitive behavioural therapy for chronic schizophrenia?
    Penadés R; Catalán R; Pujol N; Puig O; Guarch J; Masana G; Navarro V; Gastó C
    Psychother Psychosom; 2010; 79(2):129-30. PubMed ID: 20090401
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 23. Developing treatments for impaired cognition in schizophrenia.
    Minzenberg MJ; Carter CS
    Trends Cogn Sci; 2012 Jan; 16(1):35-42. PubMed ID: 22178120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electroconvulsive therapy in treatment-resistant schizophrenia: prediction of response and the nature of symptomatic improvement.
    Chanpattana W; Sackeim HA
    J ECT; 2010 Dec; 26(4):289-98. PubMed ID: 20375701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation.
    Sachdev P; Loo C; Mitchell P; Malhi G
    Psychiatry Clin Neurosci; 2005 Jun; 59(3):354-7. PubMed ID: 15896231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phenomenology, clinical diagnostics and treatment of hallucinations].
    Hubl D
    Ther Umsch; 2018 Jun; 75(1):19-29. PubMed ID: 29909766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can repetitive transcranial magnetic stimulation be considered effective treatment option for negative symptoms of schizophrenia?
    Prikryl R; Kucerova HP
    J ECT; 2013 Mar; 29(1):67-74. PubMed ID: 23303418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia.
    Jin Y; Potkin SG; Kemp AS; Huerta ST; Alva G; Thai TM; Carreon D; Bunney WE
    Schizophr Bull; 2006 Jul; 32(3):556-61. PubMed ID: 16254067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility study.
    Harel EV; Zangen A; Roth Y; Reti I; Braw Y; Levkovitz Y
    World J Biol Psychiatry; 2011 Mar; 12(2):119-26. PubMed ID: 20854181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New therapeutic approaches for treatment-resistant schizophrenia: a look to the future.
    Miyamoto S; Jarskog LF; Fleischhacker WW
    J Psychiatr Res; 2014 Nov; 58():1-6. PubMed ID: 25070124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls--a randomized placebo-controlled, double-blind fMRI study.
    Guse B; Falkai P; Gruber O; Whalley H; Gibson L; Hasan A; Obst K; Dechent P; McIntosh A; Suchan B; Wobrock T
    Behav Brain Res; 2013 Jan; 237():300-7. PubMed ID: 23022750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives on treatment needs in schizophrenia.
    Meise U; Fleischhacker WW
    Br J Psychiatry Suppl; 1996 May; (29):9-16. PubMed ID: 8733818
    [No Abstract]   [Full Text] [Related]  

  • 35. Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia.
    Poulet E; Brunelin J; Bediou B; Bation R; Forgeard L; Dalery J; d'Amato T; Saoud M
    Biol Psychiatry; 2005 Jan; 57(2):188-91. PubMed ID: 15652879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance treatment with transcranial magnetic stimulation in a patient with late-onset schizophrenia.
    Poulet E; Brunelin J; Kallel L; D'Amato T; Saoud M
    Am J Psychiatry; 2008 Apr; 165(4):537-8. PubMed ID: 18381921
    [No Abstract]   [Full Text] [Related]  

  • 37. High frequency repetitive transcranial magnetic stimulation as an augmenting strategy in severe treatment-resistant major depression: a prospective 4-week naturalistic trial.
    Berlim MT; McGirr A; Beaulieu MM; Turecki G
    J Affect Disord; 2011 Apr; 130(1-2):312-7. PubMed ID: 21056475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive behavior therapy for schizophrenia: a meta-analytical review of randomized controlled trials.
    Sarin F; Wallin L; Widerlöv B
    Nord J Psychiatry; 2011 Jun; 65(3):162-74. PubMed ID: 21563994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Negative symptoms in schizophrenia: new pharmacological approaches].
    Lodovighi MA; Palomba A; Belzeaux R; Adida M; Azorin JM
    Encephale; 2015 Dec; 41(6 Suppl 1):6S41-9. PubMed ID: 26776392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electroconvulsive therapy and schizophrenia].
    Mouchet-Mages S
    Encephale; 2007 Jun; 33 Pt 3():S415-8. PubMed ID: 19101362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.